Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicentre prospective trial for extracranial malignant germ cell tumours including a randomized comparison of Carboplatin and Cisplatin
DRKS00019921Phase 3Recruiting
- Sponsor
- University of Bonn
- Start
- Nov 2019
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised trial of carboplatin, cisplatin, etoposide and ifosfamide in Germ Cell Carcinoma (2 arms), sponsored by University of Bonn. Started Nov 2019; status: recruiting.
02
Drugs
carboplatincisplatinetoposideifosfamide
03
Conditions
Germ Cell Carcinoma
Beyond the preview
Go deeper on DRKS00019921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00019921.